The 340B Drug Discount Program, originally intended to help vulnerable patients, has become a multibillion-dollar profit ...

MI5 has offered an “unreserved” apology to the High Court saying there had been “failings and errors” in legal proceedings ...

Richard Condon, CEO Aspire Pharma, discusses successful leadership ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.

Morocco has long stood as one of the world’s top producers of hashish, with an estimated 47,000 hectares dedicated to ...

Levothyroxine, the standard treatment for an underactive thyroid, is highly sensitive to timing – and your morning coffee can ...

A British Airways cabin crew member has gone viral after being discovered dancing naked in a business class toilet mid-shift, ...

The issue is nothing new, but it has been receiving more attention as the Trump administration, lawmakers and community ...

Association of Pharmaceutical Manufacturers of Ukraine (hereinafter referred to as “AUMM”) and the Association of Employers' ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Every healthcare company claims to be working in the patient's best interest, and yet prices only seem to rise.

Artificial intelligence systems like ChatGPT provide plausible-sounding answers to any question you might ask. But they don't ...